1. Academic Validation
  2. A practical method for preparing fluorescent-labeled glycans with a 9-fluorenylmethyl derivative to simplify a fluorimetric HPLC-based analysis

A practical method for preparing fluorescent-labeled glycans with a 9-fluorenylmethyl derivative to simplify a fluorimetric HPLC-based analysis

  • J Pharm Biomed Anal. 2020 Jul 15;186:113267. doi: 10.1016/j.jpba.2020.113267.
Mitsuhiro Kinoshita 1 Ai Saito 2 Sachio Yamamoto 2 Shigeo Suzuki 2
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Sciences, Kindai University, Kowakae 3-4-1, Higashi-osaka 577-8502, Japan. Electronic address: [email protected].
  • 2 Department of Pharmaceutical Sciences, Kindai University, Kowakae 3-4-1, Higashi-osaka 577-8502, Japan.
Abstract

Analysis of glycans in glycoproteins is often performed by liquid chromatography (LC) separation coupled with fluorescence detection and/or mass spectrometric detection. Enzymatically or chemically released glycans from glycoproteins are usually labeled by reductive amination with a fluorophore reagent. Although labeling techniques based on reductive amination have been well-established as sample preparation methods for fluorometric HPLC-based glycan analysis, they often include time-consuming and tedious purification steps. Here, we reported an alternative fluorescent labeling method based on the synthesis of hydrazone and its reduction using 9-fluorenylmethyl carbazate (Fmoc-hydrazine) as a fluorophore reagent. Using isomaltopentaose and N-glycans from human IgG, we optimized the Fmoc-labeling conditions and purification procedure of Fmoc-labeled N-glycans and applied the optimized method for the analysis of N-glycans released from four glycoproteins (bovine RNase B, human fibrinogen, human α1-acid glycoprotein, and bovine fetuin). The complete workflow for preparation of fluorescent-labeled N-glycans takes a total of 3.5 h and is simple to implement. The method presented here lowers the overall cost of a fluorescently labeled N-glycan and will be practically useful for the screening of disease-related glycans or routine analysis at an early stage of development of biopharmaceuticals.

Keywords

Fluorescence detection; Fmoc-hydrazine; HPLC; N-glycans.

Figures
Products